# Avatrombopaq In Patients With Cirrhosis

> **NCT04845659** · PHASE4 · UNKNOWN · sponsor: **Hvidovre University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Thrombocytopenia; Drugs
- Cirrhosis, Liver
- Procedural Bleeding

## Interventions

- **DRUG:** Doptelet Pill

## Key facts

- **NCT ID:** NCT04845659
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04845659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04845659, "Avatrombopaq In Patients With Cirrhosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04845659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*